The United Kingdom's financial regulator this week said it would be launching a new platform later this year on which shares ...

Carriage Services shows stable earnings and improved finances, but limited upside as M&A remains paused. Find out why CSV ...

Pfizer (PFE) faces FDA rejection for expanding Talzenna's prostate cancer use, and the company halts label change efforts in the U.S. in prostate cancer. Read more here.

The AI boom may define the next decade, but most stocks are already priced for perfection. Learn why a few overlooked plays ...

Amgen beat Q1 estimates with strong margins driven by Blincyto, Prolia, and standout Imdelltra growth, plus strength in ...

There are hidden income opportunities in untapped markets. Read about the two double-digit yielding CEFs and ETFs we ...

Rumble struggles with stalled user growth, missed revenue expectations, and limited crypto pivot impact. Read an analysis of ...

DGT combines global diversification, strong technicals, solid yield, and value appeal despite a modestly higher fee and ...

HIVE has pulled back but shows bullish signs with rising estimates, strong seasonality, and surging mining/AI growth. Find ...

Palomar Holdings looks attractive after a 10% dip, with strong growth, diversification, and undervalued metrics supporting ...

The semiconductor sector rebounds post-2025 meltdown. Read here for an analysis of SMH ETF's growth, AI impacts, and ...

Murphy USA is rebounding after a pullback, with strong buybacks, improving fuel margins, and solid FCF despite Q1 weakness.